James H Kocsis

Summary

Affiliation: Cornell University
Country: USA

Publications

  1. ncbi request reprint Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, NY 10021, USA
    Psychopharmacol Bull 37:73-87. 2003
  2. ncbi request reprint Recurrent depression: patient characteristics, clinical course, and current recommendations for management
    James H Kocsis
    Weill Cornell Medical College, New York, NY 10021, USA
    CNS Spectr 11:6-11. 2006
  3. pmc Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical Center, 525 East 68th Street, New York, NY 10021, USA
    J Affect Disord 110:55-61. 2008
  4. ncbi request reprint Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, N Y, USA
    J Clin Psychiatry 70:354-61. 2009
  5. pmc Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, USA
    Arch Gen Psychiatry 66:1178-88. 2009
  6. doi request reprint A new scale for assessing the quality of randomized clinical trials of psychotherapy
    James H Kocsis
    Weill Cornell Medical College, New York, NY 10065, USA
    Compr Psychiatry 51:319-24. 2010
  7. ncbi request reprint Pharmacotherapy for chronic depression
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical Center, New York, NY 10021, USA
    J Clin Psychol 59:885-92. 2003
  8. ncbi request reprint Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo
    James H Kocsis
    Cornell University School of Medicine, New York, New York, USA
    Arch Gen Psychiatry 59:723-8. 2002
  9. ncbi request reprint Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, NY 10012, USA
    J Clin Psychiatry 68:1014-23. 2007
  10. ncbi request reprint Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression
    Alan J Gelenberg
    Department of Psychiatry, Health Sciences Center, University of Arizona, PO Box 245002, Tucson, AZ 85724 5002, USA
    Biol Psychiatry 54:806-17. 2003

Research Grants

  1. REVAMP Follow-Up Study
    JAMES KOCSIS; Fiscal Year: 2007

Detail Information

Publications28

  1. ncbi request reprint Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, NY 10021, USA
    Psychopharmacol Bull 37:73-87. 2003
    ..COMB was associated with less symptom re-emergence during the continuation phase than either monotherapy, particularly for partial remitters...
  2. ncbi request reprint Recurrent depression: patient characteristics, clinical course, and current recommendations for management
    James H Kocsis
    Weill Cornell Medical College, New York, NY 10021, USA
    CNS Spectr 11:6-11. 2006
    ..Additionally, recent developments in genetic and psychological vulnerability research have sought to further improve outcomes by identifying markers in patients who may likely experience multiple depressive episodes...
  3. pmc Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical Center, 525 East 68th Street, New York, NY 10021, USA
    J Affect Disord 110:55-61. 2008
    ..These results and the consistency of similar results over time point to the dire need for patient and provider education regarding the signs and symptoms of depression and its treatment...
  4. ncbi request reprint Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, N Y, USA
    J Clin Psychiatry 70:354-61. 2009
    ..We hypothesized that patient preference at baseline would interact with treatment group to differentially affect treatment outcome...
  5. pmc Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, USA
    Arch Gen Psychiatry 66:1178-88. 2009
    ..Previous studies have found that few chronically depressed patients remit with antidepressant medications alone...
  6. doi request reprint A new scale for assessing the quality of randomized clinical trials of psychotherapy
    James H Kocsis
    Weill Cornell Medical College, New York, NY 10065, USA
    Compr Psychiatry 51:319-24. 2010
    ..In 2004, the American Psychiatric Association's Committee on Research on Psychiatric Treatments appointed a subcommittee to investigate the status of empirical evidence with regard to psychodynamic psychotherapy...
  7. ncbi request reprint Pharmacotherapy for chronic depression
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical Center, New York, NY 10021, USA
    J Clin Psychol 59:885-92. 2003
    ..Short-term trials seem reasonably conclusive in establishing the effectiveness of antidepressants for dysthymia and double depression, although rates of remission fall short of 50%...
  8. ncbi request reprint Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo
    James H Kocsis
    Cornell University School of Medicine, New York, New York, USA
    Arch Gen Psychiatry 59:723-8. 2002
    ..To date, no study has measured psychosocial functioning in this population during long-term maintenance antidepressant treatment or following the double-blind discontinuation of treatment...
  9. ncbi request reprint Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, NY 10012, USA
    J Clin Psychiatry 68:1014-23. 2007
    ..To test the long-term efficacy and safety of venlafaxine extended-release (ER) in preventing recurrence in patients with major depression...
  10. ncbi request reprint Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression
    Alan J Gelenberg
    Department of Psychiatry, Health Sciences Center, University of Arizona, PO Box 245002, Tucson, AZ 85724 5002, USA
    Biol Psychiatry 54:806-17. 2003
    ..This randomized, placebo-controlled study of the efficacy and safety of nefazodone in preventing recurrence was conducted for patients with chronic MDD...
  11. ncbi request reprint Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    Neuropsychopharmacology 30:405-16. 2005
    ..Global patient ratings such as the PGI-I, as opposed to specific item-based ratings, provide less valid findings...
  12. ncbi request reprint REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design
    Madhukar H Trivedi
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Psychopharmacol Bull 41:5-33. 2008
    ....
  13. ncbi request reprint The state of knowledge of chronic depression
    Alan J Gelenberg
    Department of Psychiatry, Arizona Health Sciences Center, Tucson, AZ, USA
    J Clin Psychiatry 67:179-84. 2006
  14. ncbi request reprint The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9086, USA
    Biol Psychiatry 54:573-83. 2003
    ..The QIDS-SR(16) has highly acceptable psychometric properties, which supports the usefulness of this brief rating of depressive symptom severity in both clinical and research settings...
  15. ncbi request reprint Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression
    Michael E Thase
    Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, 3811 O Hara St, Pittsburgh, PA 15213, USA
    Arch Gen Psychiatry 59:233-9. 2002
    ..Although various strategies have been proposed to treat antidepressant nonresponders, little controlled research has been published that examines prospectively the use of switching to an alternate antidepressant...
  16. ncbi request reprint Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence
    John C Markowitz
    Department of Psychiatry, Weill Medical College of Cornell University, New York, New York 10032, USA
    J Nerv Ment Dis 196:468-74. 2008
    ..Results suggest IPT may have specific antidepressant benefits for dysthymic alcoholic patients but not in treating alcoholism...
  17. doi request reprint A quality-based review of randomized controlled trials of psychodynamic psychotherapy
    Andrew J Gerber
    Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, New York, 10032, USA
    Am J Psychiatry 168:19-28. 2011
    ..The authors report results from application of the RCT-PQRS to 94 randomized controlled trials of psychodynamic psycho-therapy published between 1974 and May 2010...
  18. doi request reprint A quality-based review of randomized controlled trials of cognitive-behavioral therapy for depression: an assessment and metaregression
    Nathan C Thoma
    Weill Cornell Medical College, New York, New York, USA
    Am J Psychiatry 169:22-30. 2012
    ..The authors also sought to examine the relationship between quality and outcome in the CBT trials...
  19. ncbi request reprint HPA axis activation in major depression and response to fluoxetine: a pilot study
    Elizabeth A Young
    Department of Psychiatry, The Mental Health Research Institute, University of Michigan, 205 Zina Pitcher Place, Ann Arbor, MI 48109 0729, USA
    Psychoneuroendocrinology 29:1198-204. 2004
    ..This may reflect the greater severity of subjects with HPA axis dysregulation or the need to normalize the HPA axis with medications for optimal response...
  20. ncbi request reprint Lack of ventral striatal response to positive stimuli in depressed versus normal subjects
    Jane Epstein
    Department of Psychiatry, Box 140, Weill Medical College of Cornell University, 1300 York Ave, New York, NY 10021, USA
    Am J Psychiatry 163:1784-90. 2006
    ....
  21. ncbi request reprint Alternative interpretation of Swedish twin study findings on personality and major depression
    James H Kocsis
    Arch Gen Psychiatry 64:1096. 2007
  22. ncbi request reprint Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression
    Daniel N Klein
    Department of Psychology, State University of New York at Stony Brook, Stony Brook, NY 11794, USA
    J Consult Clin Psychol 72:681-8. 2004
    ..The 2 conditions also differed significantly on change in depressive symptoms over time. These findings support the use of CBASP as a maintenance treatment for chronic forms of MDD...
  23. ncbi request reprint Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not
    Alan F Schatzberg
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5717, USA
    Arch Gen Psychiatry 62:513-20. 2005
    ..Although various strategies are available to manage nonresponders to an initial treatment for depression, no controlled trials address the utility of switching from an antidepressant medication to psychotherapy or vice versa...
  24. ncbi request reprint A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients
    John C Markowitz
    Department of Psychiatry, Weill Medical College of Cornell University, United States
    J Affect Disord 89:167-75. 2005
    ..This article reports outcomes of an acute randomized trial of 94 subjects treated for 16 weeks with either interpersonal psychotherapy (IPT), brief supportive psychotherapy (BSP), sertraline, or sertraline plus IPT...
  25. ncbi request reprint The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases
    Martin B Keller
    Brown University, Providence, Rhode Island 02906, USA
    Biol Psychiatry 62:1371-9. 2007
    ..We evaluated the comparative efficacy and safety of venlafaxine extended release (ER) and fluoxetine in the acute and continuation phases of treatment...
  26. pmc Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone
    Rachel Manber
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Consult Clin Psychol 76:459-67. 2008
    ..The authors conclude that combined antidepressant medications and psychotherapy result in faster full remission of chronic forms of major depressive disorder...
  27. ncbi request reprint Dropouts versus completers among chronically depressed outpatients
    Bruce A Arnow
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5722, United States
    J Affect Disord 97:197-202. 2007
    ..Premature termination is common among patients treated for depression with either pharmacotherapy or psychotherapy. Yet little is known about factors associated with premature treatment termination among depressed patients...
  28. ncbi request reprint The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases
    Martin B Keller
    Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
    J Clin Psychiatry 68:1246-56. 2007
    ..To report second-year results from the 2-year maintenance phase of a long-term study to evaluate the efficacy and safety of venlafaxine extended release (ER) in preventing recurrence of depression...

Research Grants2

  1. REVAMP Follow-Up Study
    JAMES KOCSIS; Fiscal Year: 2007
    ....